Over the past decade, immunotherapy has revolutionized cancer treatment, improving the chance for cure and survival even for poor-prognosis tumors. Immune ...

GEN2 is well tolerated with minimal toxicity and signs of pharmacodynamic activity in an ongoing Phase 1 dose escalation and ...

"This represents a significant step forward for the IMNN-001 development program as we work toward bringing patients this novel IL-12 immunotherapy ... with advanced ovarian cancer who have not seen ...

“Thanks to advancements in early detection, treatment and research, the five-year survival rate has improved by 17% over the past five years in Illinois. Raising awareness and funds for lung cancer ...

Topical therapy means the drug is a cream or ointment put right onto the cancer. This is a way to treat vulvar intraepithelial neoplasia (VIN), but it's not used to treat invasive vulvar cancer.

Prof. Louise Emmett: "This collaborative Frontiers grant gives us the tools to deeply evaluate optimal combinations with targeted alpha therapy in prostate cancer – aiming for longer better ...

Less than a year after his coronation, the King was diagnosed with an undisclosed cancer, which was found while he was undergoing treatment for a separate issue relating to an enlarged prostate.

the cause of the cancer is unknown. Surgery is sometimes an option for those diagnosed with glioblastoma if it has not grown too deep into the brain. Chemotherapy and radiation therapy are also ...

If you have bladder cancer, there are several treatment options. Your doctor will help you decide which one is best for you. Choosing the best treatment depends on a number of things ...

The overall performance of IL-23 p19 inhibitors for the treatment of IBD was evaluated ... selectivity by specifically inhibiting the IL-12-dependent T-cell pathways that were involved in infection ...

The two lead cancer programs are CB-010, a CD19-targeting cell therapy in development for B cell non-Hodgkin lymphoma, and CB-011, a BCMA-targeting cell therapy in development for multiple myeloma.